Today: 28 June 2026
Mortgage rates today: 30-year nudges higher as Rocket, UWM stocks slide on oil-driven yield jitters

Mortgage rates today: 30-year nudges higher as Rocket, UWM stocks slide on oil-driven yield jitters

New York, March 3, 2026, 13:13 EST — Regular session underway.

  • After a brief period of slipping, the 30-year fixed mortgage rate ticked higher from Monday.
  • Mortgage lenders slipped, and homebuilder ETFs followed them lower in the afternoon, pressured by rising Treasury yields.
  • Oil prices, potential Fed rate cuts, and Friday’s U.S. jobs report are all on investors’ radar.

Mortgage rates edged up on Tuesday, with Mortgage News Daily putting the 30-year fixed at 6.15%, up from 6.12% the previous day—just a 3 basis point move. Rocket Companies slid 2.1% to $16.43. UWM Holdings dropped 2.2%, ending at $4.24. loanDepot lost 3.1% to close at $1.86. Homebuilder ETFs ITB and XHB also slipped, down roughly 1.5% and 1.7%, respectively.

Timing is key right now, with borrowing costs sticking close to highs last reached in 2022 — even minor rate shifts can nudge a buyer’s monthly payment up or down. For lenders, that makes the line between a solid refinance stream and a sluggish quarter awfully thin.

With markets adjusting their view on inflation risk, rates are once again tracking shifts in Treasury yields. Rohan Khanna, who leads euro rates strategy at Barclays, called it a return to the “2022 energy-shock template.” Reuters

U.S. stocks lost ground across the board, with investors eyeing the possibility that pricier oil might keep inflation sticky—posing fresh challenges for the Federal Reserve. “The main concern is that (oil prices) goes to over $100 a barrel and stays there,” said Robert Pavlik, senior portfolio manager at Dakota Wealth. The 10-year Treasury yield jumped to a one-week high, and traders dialed back their rate-cut bets. Reuters

Borrowing costs have eased from last year, but housing supply hasn’t budged. Realtor.com estimates the shortfall for 2025 at 4.03 million homes. “Without a sustained and targeted increase in housing supply, affordability challenges will continue to sideline many would-be buyers,” said chief economist Danielle Hale. Reuters

Some rate trackers aimed at consumers are still quoting numbers under 6%, though it hinges on individual assumptions and borrower details. On Tuesday, Zillow’s Home Loans page was showing a 30-year fixed rate at 5.99%.

Rocket shares had already been sliding ahead of Tuesday, dropping 7.7% Monday and trailing other mortgage names, according to MarketWatch.

The drop in mortgage rates could be short-lived. Should energy prices remain high and push yields up, lenders and homebuilders may run into more hesitation from buyers, particularly those entering the market for the first time.

Friday brings the February U.S. jobs report at 8:30 a.m. ET, with the Fed’s March 17-18 policy meeting on deck.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Dave Ramsey Advises Lump-Sum Investment Over Dollar-Cost Averaging Despite Market Volatility
    June 28, 2026, 1:44 PM EDT. Personal finance expert Dave Ramsey recommends investing a full $350,000 lump sum into the S&P 500 rather than dollar-cost averaging, citing long-term market growth benefits. He warns investors to expect volatility, especially with President Trump likely to cause unpredictable market moves, but emphasizes staying calm and committed to the process. Ramsey illustrated with a hypothetical 25% market gain, showing lump-sum investments outperform gradual investing due to longer market exposure. Despite acknowledging the emotional difficulty, he stressed that dollar-cost averaging suits those prone to panic during sudden drops. Historical market recoveries after shocks like the COVID-19 crash underpin his advice to remain invested amid geopolitical and economic uncertainties.

Latest articles

Energy stocks this week: U.S. sector ETF holds flat as oil falls

Energy stocks this week: U.S. sector ETF holds flat as oil falls

28 June 2026
Brent crude plunged 10.86% last week as Hormuz flows improved, but the Energy Select Sector SPDR Fund (XLE) fell just 0.4%, signaling investors are no longer trading energy stocks in lockstep with oil prices; this divergence matters now as refiners benefit from tight diesel margins while oilfield services face risks from a Norway lockout and rising U.S. rigs.
Micron (NASDAQ:MU) moves pull Nvidia (NASDAQ:NVDA), Apple (NASDAQ:AAPL) into focus this week for AI stocks

Micron (NASDAQ:MU) moves pull Nvidia (NASDAQ:NVDA), Apple (NASDAQ:AAPL) into focus this week for AI stocks

28 June 2026
Micron’s record $41.46 billion quarter and $50 billion Q4 outlook highlight surging memory demand as Apple hikes Mac and iPad prices after DRAM costs nearly double; with the Philadelphia semiconductor index down 7.9% last week, investors face a compressed four-day week to gauge if AI’s memory squeeze boosts profits or triggers a tech cost shock, as payrolls data and rate risks loom.
US stocks look to jobs data as traders shift from AI tech

US stocks look to jobs data as traders shift from AI tech

28 June 2026
Semiconductor stocks plunged 7.9% last week, their worst performance since April, dragging the S&P 500 down 2.05% as investors pulled nearly $20 billion from tech funds; strategists warn that continued weakness in mega-cap tech could weigh on cap-weighted indexes even as smaller stocks rally, with upcoming jobs data and rate expectations posing further risks.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

Stock Market Today 03.03.2026

Eli Lilly stock slips again as April orforglipron decision and FDA GLP-1 ad crackdown loom
Next Story

Eli Lilly stock slips again as April orforglipron decision and FDA GLP-1 ad crackdown loom

Go toTop